IMPACT OF UNDIAGNOSED PREDIABETES ON PHOSPHODIESTERASE TYPE 5 INHIBITORS RESPONSE IN MEN WITH ERECTILE DYSFUNCTION

被引：0
|
作者：
Capogrosso, P. [1 ]
Boeri, L. [2 ]
Ventimiglia, E. [2 ]
Cazzaniga, W. [2 ]
Pozzi, E. [3 ]
Schifano, N. [2 ]
Chierigo, F. [2 ]
Abbate, C. [2 ]
Montanari, E. [4 ]
Montorsi, F. [2 ]
Salonia, A. [2 ]
机构：
[1] Osped San Raffaele, IRCCS, Unit Urol, Milan, Italy
[2] Osped San Raffaele, Milan, Italy
[3] San Raffaele Univ, Milan, Italy
[4] Osped Policlin, Milan, Italy
来源：
JOURNAL OF SEXUAL MEDICINE | 2019年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO-01-014
引用
收藏
页码：S52 / S53
页数：2
相关论文
共 50 条
  • [41] Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma
    Loeb, Stacy
    Folkvaljon, Yasin
    Lambe, Mats
    Robinson, David
    Garmo, Hans
    Ingvar, Christian
    Stattin, Par
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (24): : 2449 - 2455
  • [42] Recreation use of phosphodiesterase type 5 inhibitors, the other side of erectile dysfunction
    Fusco, Giovanni Maria
    Cirillo, Luigi
    Mastrangelo, Francesco
    Romano, Francesco
    di Mauro, Ernesto
    Cacace, Gianluigi
    Spena, Gianluca
    Iannicelli, Annamaria
    Franzese, Corrado Aniello
    Mirone, Vincenzo
    La Rocca, Roberto
    Napolitano, Luigi
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2023, 95 (02) : 129 - 130
  • [43] Comparison of treatment of erectile dysfunction with phosphodiesterase TYPE 5 inhibitors and other modalities
    Chandrasekar, P.
    Krishnamurthy, G.
    Sundarajan, V.
    Potluri, B.
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 : 113 - 113
  • [44] Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors
    Fleshner, N
    Harvey, M
    Adomat, H
    Wood, C
    Eberding, A
    Hersey, K
    Guns, E
    JOURNAL OF UROLOGY, 2005, 174 (02): : 636 - 641
  • [45] Evaluation and diagnostic testing of erectile dysfunction in the era of phosphodiesterase type 5 inhibitors
    Jacobsohn, Kenneth
    Wang, Run
    ASIAN JOURNAL OF ANDROLOGY, 2007, 9 (01) : 3 - 7
  • [46] Comparison of treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors and other modalities
    Chandrasekar, Ponnambalam
    Krishnamurthy, Gokul
    Sundarajan, V.
    Potluri, Bernard
    JOURNAL OF ENDOUROLOGY, 2007, 21 : A60 - A60
  • [47] Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus
    Vickers, MA
    Satyanarayana, R
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (06) : 466 - 471
  • [48] Phosphodiesterase Type 5 Inhibitors for the Management of Erectile Dysfunction: Preference and Adherence to Treatment
    Al-Shaiji, T. F.
    Brock, G. B.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (30) : 3486 - 3495
  • [49] Phosphodiesterase-5 inhibitors for male erectile dysfunction
    Sui, ZH
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (09) : 1373 - 1388
  • [50] Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study
    Hatzichristou, D.
    Haro, J. M.
    Martin-Morales, A.
    von Keitz, A.
    Riley, A.
    Bertsch, J.
    Belger, M.
    Wolka, A. M.
    Beardsworth, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (11) : 1850 - 1862
12345